See the DrugPatentWatch profile for Difluprednate
Difluprednate 0.05% is a topical ophthalmic corticosteroid used to treat inflammation and pain following ocular surgery [1][2]. It is available in a 0.05% emulsion formulation [1].
How does Difluprednate 0.05% work?
Difluprednate is a potent corticosteroid that works by suppressing inflammation. It inhibits the release of inflammatory mediators, such as prostaglandins and cytokines, thereby reducing redness, swelling, and discomfort in the eye [3]. The emulsion formulation is designed to enhance ocular penetration and retention [4].
What conditions does Difluprednate 0.05% treat?
This medication is primarily prescribed to manage postoperative inflammation and pain after cataract surgery and other ophthalmic surgical procedures [1][2].
What are the potential side effects of Difluprednate 0.05%?
Common side effects include blurred vision, eye irritation, conjunctival hyperemia (redness), and increased intraocular pressure [2]. Less common but more serious side effects can include glaucoma, cataracts, and secondary ocular infections [2][5]. Patients should report any persistent or worsening symptoms to their eye care professional [2].
When does the patent for Difluprednate 0.05% expire?
Information regarding specific patent expiry dates for difluprednate is not publicly available in a consolidated format. However, patent and exclusivity data for pharmaceuticals can be tracked through resources like DrugPatentWatch.com, which provides detailed information on patent status and expiration timelines for various drugs [6].
What are alternative treatments for post-operative eye inflammation?
Other topical corticosteroids, such as loteprednol, fluorometholone, and prednisolone acetate, are also used to treat ocular inflammation. Non-steroidal anti-inflammatory drugs (NSAIDs) may also be prescribed in conjunction with or as an alternative to corticosteroids, depending on the specific clinical situation [7][8].
Who manufactures Difluprednate 0.05%?
The brand name for difluprednate 0.05% ophthalmic emulsion is Durezol, which is manufactured by Alcon [1]. Generic versions may also be available from other pharmaceutical companies.
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.aao.org/eye-health/medicines/difluprednate
[3] https://pubmed.ncbi.nlm.nih.gov/16380347/
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787714/
[5] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2840758/
[6] https://www.drugpatentwatch.com/
[7] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878554/
[8] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770732/